Travere Therapeutics (TVTX) Operating Income Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 55.96% |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | 27.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.62% |
| Dec 31, 2025 | 27.95% |
| Sep 30, 2025 | 32.04% |
| Jun 30, 2025 | 45.59% |
| Mar 31, 2025 | 15.99% |
| Dec 31, 2024 | 10.55% |
| Sep 30, 2024 | -20.98% |
| Jun 30, 2024 | -24.23% |
| Mar 31, 2024 | -43.07% |
| Dec 31, 2023 | 7.37% |
| Sep 30, 2023 | -68.26% |
| Jun 30, 2023 | -65.07% |
| Mar 31, 2023 | -86.27% |
| Dec 31, 2022 | -45.47% |
| Sep 30, 2022 | -33.86% |
| Jun 30, 2022 | -29.06% |
| Mar 31, 2022 | -23.48% |
| Dec 31, 2021 | -157.23% |
| Sep 30, 2021 | 3.77% |
| Jun 30, 2021 | -17.88% |
| Mar 31, 2021 | -38.46% |
| Dec 31, 2020 | -98.41% |
| Sep 30, 2020 | -22.36% |
| Jun 30, 2020 | -19.34% |
| Mar 31, 2020 | -1.50% |
| Dec 31, 2019 | -15.62% |
| Sep 30, 2019 | -19.12% |
| Jun 30, 2019 | -47.52% |
| Mar 31, 2019 | -66.78% |
| Dec 31, 2018 | 31.04% |
| Sep 30, 2018 | -20.19% |
| Jun 30, 2018 | -45.89% |
| Mar 31, 2018 | -30.26% |
| Dec 31, 2017 | 6.72% |
| Sep 30, 2017 | 21.43% |
| Jun 30, 2017 | 7.50% |
| Mar 31, 2017 | 13.24% |
| Dec 31, 2016 | -16.11% |
| Sep 30, 2016 | -50.04% |
| Jun 30, 2016 | -39.24% |
| Mar 31, 2016 | -54.15% |